BDNF mRNA is decreased in the hippocampus of individuals with Alzheimer's disease - PubMed (original) (raw)
BDNF mRNA is decreased in the hippocampus of individuals with Alzheimer's disease
H S Phillips et al. Neuron. 1991 Nov.
Abstract
In recent years, nerve growth factor (NGF) has gained attention as a potential therapeutic agent for Alzheimer's disease (AD). To study the expression of NGF and its homologs, brain-derived neurotrophic factor (BDNF) and neurotrophin 3 (NT-3), postmortem samples of hippocampus from AD and control donors were examined by in situ hybridization. Hybridization signal for BDNF, but not NGF or NT-3, was decreased in samples of hippocampus from donors with AD. Decreased transcript abundance of BDNF mRNA in hippocampi of individuals with AD was verified by an RNAase protection assay. These results suggest the possibility that decreased expression of BDNF may contribute to the progression of cell death in AD.
Similar articles
- Brain-derived neurotrophic factor and neurotrophin-4 increase neurotrophin-3 expression in the rat hippocampus.
Lindholm D, da Penha Berzaghi M, Cooper J, Thoenen H, Castrén E. Lindholm D, et al. Int J Dev Neurosci. 1994 Dec;12(8):745-51. doi: 10.1016/0736-5748(94)90054-x. Int J Dev Neurosci. 1994. PMID: 7747601 - Expanded distribution of mRNA for nerve growth factor, brain-derived neurotrophic factor, and neurotrophin 3 in the rat brain after colchicine treatment.
Ceccatelli S, Ernfors P, Villar MJ, Persson H, Hökfelt T. Ceccatelli S, et al. Proc Natl Acad Sci U S A. 1991 Nov 15;88(22):10352-6. doi: 10.1073/pnas.88.22.10352. Proc Natl Acad Sci U S A. 1991. PMID: 1946455 Free PMC article. - The synthesis of nerve growth factor and brain-derived neurotrophic factor in hippocampal and cortical neurons is regulated by specific transmitter systems.
Thoenen H, Zafra F, Hengerer B, Lindholm D. Thoenen H, et al. Ann N Y Acad Sci. 1991;640:86-90. doi: 10.1111/j.1749-6632.1991.tb00196.x. Ann N Y Acad Sci. 1991. PMID: 1776765 Review. - Growth Factor Gene Therapy for Alzheimer's Disease.
Tuszynski MH. Tuszynski MH. J Alzheimers Dis. 2024;101(s1):S433-S441. doi: 10.3233/JAD-240545. J Alzheimers Dis. 2024. PMID: 39422960 Review.
Cited by
- Alzheimer's β-secretase (BACE1) regulates the cAMP/PKA/CREB pathway independently of β-amyloid.
Chen Y, Huang X, Zhang YW, Rockenstein E, Bu G, Golde TE, Masliah E, Xu H. Chen Y, et al. J Neurosci. 2012 Aug 15;32(33):11390-5. doi: 10.1523/JNEUROSCI.0757-12.2012. J Neurosci. 2012. PMID: 22895721 Free PMC article. - Dentate Gyrus Granule Cells Show Stability of BDNF Protein Expression in Mossy Fiber Axons with Age, and Resistance to Alzheimer's Disease Neuropathology in a Mouse Model.
Criscuolo C, Chartampila E, Ginsberg SD, Scharfman HE. Criscuolo C, et al. eNeuro. 2024 Mar 4;11(3):ENEURO.0192-23.2023. doi: 10.1523/ENEURO.0192-23.2023. Print 2024 Mar. eNeuro. 2024. PMID: 38164567 Free PMC article. - Human immunodeficiency virus-associated dementia: a link between accumulation of viral proteins and neuronal degeneration.
Mocchetti I, Bachis A, Esposito G, Turner SR, Taraballi F, Tasciotti E, Paige M, Avdoshina V. Mocchetti I, et al. Curr Trends Neurol. 2014;8:71-85. Curr Trends Neurol. 2014. PMID: 26069421 Free PMC article. - Progesterone, brain-derived neurotrophic factor and neuroprotection.
Singh M, Su C. Singh M, et al. Neuroscience. 2013 Jun 3;239:84-91. doi: 10.1016/j.neuroscience.2012.09.056. Epub 2012 Oct 2. Neuroscience. 2013. PMID: 23036620 Free PMC article. Review. - MicroRNA-134-5p inhibition rescues long-term plasticity and synaptic tagging/capture in an Aβ(1-42)-induced model of Alzheimer's disease.
Baby N, Alagappan N, Dheen ST, Sajikumar S. Baby N, et al. Aging Cell. 2020 Jan;19(1):e13046. doi: 10.1111/acel.13046. Epub 2019 Oct 17. Aging Cell. 2020. PMID: 31625272 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials